Biorestorative Therapies Inc (BRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 19 | 38 | 16 | 20 | 7 |
| Gross Profit | 19 | 38 | 16 | 20 | 7 |
| Operating Expenses | 2,250 | 1,610 | 1,760 | 2,589 | 2,496 |
| Operating Income | -2,231 | -1,572 | -1,744 | -2,569 | -2,489 |
| Interest Expense | 161 | 161 | 114 | 95 | 98 |
| Other Income | -116 | -127 | -194 | -83 | -199 |
| Pre-tax Income | -2,508 | -1,860 | -2,052 | -2,747 | -2,786 |
| Net Income Continuous | -2,508 | -1,860 | -2,052 | -2,747 | -2,786 |
| Net Income | $-2,508 | $-1,860 | $-2,052 | $-2,747 | $-2,786 |
| EPS Basic Total Ops | -1,300.00 | -1,000.00 | -1,233.33 | -1,700.00 | -1,866.67 |
| EPS Basic Continuous Ops | -1,307.50 | -1,017.30 | -1,231.15 | -1,695.16 | -1,862.76 |
| EPS Diluted Total Ops | -1,300.00 | -1,000.00 | -1,233.33 | -1,700.00 | -1,866.67 |
| EPS Diluted Continuous Ops | -1,307.50 | -1,017.30 | -1,231.15 | -1,695.16 | -1,862.76 |
| EBITDA(a) | $-1,909 | $-1,266 | $-1,518 | $-2,420 | $-2,292 |